Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Men with alopecia areata have different body fat distribution compared to healthy men.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Alopecia areata patients often have undetected thyroid issues, so routine thyroid screening is recommended.

Atopic dermatitis significantly increases the risk of alopecia areata, especially in children.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

People with alopecia areata have a higher risk of heart disease.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Homeopathy successfully treated complete hair loss in a man.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

Both treatments are safe and effective, but anthralin may work better for some patients.

Alopecia areata might help slow down certain cancers.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Baricitinib shows promise for treating alopecia areata with mild side effects.